REACTION OF HUMAN ENDOTHELIAL-CELLS TO BOVINE HEMOGLOBIN-SOLUTIONS AND TUMOR-NECROSIS-FACTOR

被引:29
|
作者
SIMONI, J [1 ]
SIMONI, G [1 ]
LOX, CD [1 ]
FEOLA, M [1 ]
机构
[1] TEXAS TECH UNIV, HLTH SCI CTR, DEPT OBSTET & GYNECOL, LUBBOCK, TX 79430 USA
来源
ARTIFICIAL CELLS BLOOD SUBSTITUTES AND BIOTECHNOLOGY | 1994年 / 22卷 / 03期
关键词
D O I
10.3109/10731199409117911
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Human umbilical vein endothelial cells (HUVEC) were incubated for 24 hours with 0.1 mM or 0.3 mM of: [A] unmodified (U) Hb-(FeO2)-O-II; [B] UHb-Fe-III; [C] UHb-Fe-IV-OH; [D] polymerized low molecular weight Hb(< 400 kDa); [E] polymerized high molecular weight Hb(< 1,020 kDa); [F] polymerized low molecular weight Hb + Endotoxin (2.5 EU/mL); [G] rTNF alpha 100 pg/mL; [H] rTNF alpha 400 pg/mL; [I] rTNF alpha 800 pg/mL. The medium of the incubation was tested for LDH (index of cell injury), and for cytokines GM-CSF and IL-1a released by the cells. The data suggests that oxidation status of the iron in the Hb molecule and concentration of Hb play an important role in causing EC injury. The highest toxicity was observed when EC were incubated with 0.1 mM of UHb-Fe-IV-OH (ferryl-Hb) and no toxicity with 0.3 mM of Hb-Fe-III (ferric-Hb). The direct stimulation of EC by Hb for the production of IL-1 was limited, related only to high molecular weight Hb polymers or to Hb+E, however GM-CSF expression was increased by almost all Hb forms. TNF induced dose-related injury (R(2)=0.986), and dose-related release of IL-1 (R(2)=0.977). A different EC reaction was observed on the release of GM-CSF. Intermediate levels of TNF (400 pg/mL) increased the expression of this cytokine, while high levels (800 pg/mL) blocked its release.
引用
收藏
页码:777 / 787
页数:11
相关论文
共 50 条
  • [1] TUMOR-NECROSIS-FACTOR REDUCES LIFE-SPAN OF HUMAN ENDOTHELIAL-CELLS INVITRO
    SHIMADA, Y
    ITO, H
    KAJI, K
    FUKUDA, M
    MECHANISMS OF AGEING AND DEVELOPMENT, 1990, 55 (03) : 245 - 254
  • [2] TUMOR-NECROSIS-FACTOR INCREASES CYCLOOXYGENASE ACTIVITY IN HUMAN UMBILICAL VEIN ENDOTHELIAL-CELLS
    CARLTON, DP
    JONES, DA
    WHATLEY, RE
    ZIMMERMAN, GA
    MCINTYRE, TM
    PRESCOTT, SM
    CLINICAL RESEARCH, 1992, 40 (02): : A193 - A193
  • [3] INHIBITION OF TUMOR-INDUCED MIGRATION OF BOVINE CAPILLARY ENDOTHELIAL-CELLS BY MOUSE AND RABBIT TUMOR-NECROSIS-FACTOR
    MANOHIRANO, Y
    SATO, N
    SAWASAKI, Y
    HARANAKA, K
    SATOMI, N
    NARIUCHI, H
    GOTO, T
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 78 (01) : 115 - 120
  • [4] EFFECTS OF TUMOR-NECROSIS-FACTOR AND RELATED CYTOKINES ON VASCULAR ENDOTHELIAL-CELLS
    POBER, JS
    CIBA FOUNDATION SYMPOSIA, 1987, 131 : 170 - 184
  • [5] TUMOR-NECROSIS-FACTOR REDUCES PROTEOGLYCAN SYNTHESIS IN CULTURED ENDOTHELIAL-CELLS
    RAMASAMY, S
    LIPKE, DW
    MCCLAIN, CJ
    HENNIG, B
    JOURNAL OF CELLULAR PHYSIOLOGY, 1995, 162 (01) : 119 - 126
  • [6] TUMOR-NECROSIS-FACTOR INHIBITS THE PROLIFERATION OF CULTURED CAPILLARY ENDOTHELIAL-CELLS
    SCHWEIGERER, L
    MALERSTEIN, B
    GOSPODAROWICZ, D
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1987, 143 (03) : 997 - 1004
  • [7] INHIBITION OF TUMOR-NECROSIS-FACTOR INDUCED ADHESION MOLECULE EXPRESSION IN HUMAN AORTIC ENDOTHELIAL-CELLS
    FERGUSON, E
    BOSCHELLI, D
    NEWTON, RS
    SAXENA, U
    WOLLE, J
    FASEB JOURNAL, 1995, 9 (03): : A127 - A127
  • [8] HETEROGENEOUS RESPONSES OF HUMAN ENDOTHELIAL-CELLS TO TUMOR-NECROSIS-FACTOR WITH RESPECT TO GROWTH-INHIBITION
    SHIMADA, Y
    KAJI, K
    ITO, H
    ARTERY, 1991, 18 (05) : 268 - 284
  • [9] TUMOR-NECROSIS-FACTOR ALTERS CYTOSKELETAL ORGANIZATION AND BARRIER FUNCTION OF ENDOTHELIAL-CELLS
    CAMUSSI, G
    TURELLO, E
    BUSSOLINO, F
    BAGLIONI, C
    INTERNATIONAL ARCHIVES OF ALLERGY AND APPLIED IMMUNOLOGY, 1991, 96 (01): : 84 - 91
  • [10] FACTORS THAT DEFINE THE SUSCEPTIBILITY OF ENDOTHELIAL-CELLS TO TUMOR-NECROSIS-FACTOR AND LIPID-A
    VANDEWIEL, PA
    WEITENBERG, ES
    VANDERPIJL, A
    BLOKSMA, N
    IMMUNOPHARMACOLOGY, 1992, 23 (01): : 49 - 56